Engagement of the B cell receptor (BCR) leads to the activation of tyrosine kinases and other signaling molecules that ultimately determine the type and magnitude of the B lymphocyte's cellular response. The adaptor protein BLNK/SLP-65 plays a pivotal role in BCR signal transduction by coupling Syk activation to downstream elements such as Grb2, phospholipase C-γ, Vav and Nck. We have generated BLNK -/-mice to determine the physiological role of this protein in B cell development and activation. BLNK -/-mice exhibit an incomplete block in B cell development with a severe inhibition of pro-B to pre-B cell differentiation. BLNK -/-sIgM ⍣ cells can develop, seed the peripheral lymphoid tissues and accumulate in numbers overtime. However, these mutant B cells failed to mature and are non-responsive to BCR cross-linking in terms of proliferation and upregulation of activation markers such as CD69 and CD86 (B7-2). In addition, the CD5 ⍣ subset of B cells is absent. The immune response to T cell-independent antigen but not T cell-dependent antigen is also impaired. Overall, the phenotype of BLNK -/-mice bears a striking resemblance to that of xid mice which is the murine model of human XLA that has a mutation in Bruton's tyrosine kinase. This raises the interesting possibility that mutation in BLNK/SLP-65 may be responsible for certain human immunodeficiencies.
Introduction
The pre-B cell receptor (pre-BCR) and the BCR play pivotal Signal transduction events have been studied extensively in B lymphocytes. Engagement of the BCR activates cytoplasmic roles in the development of B lymphocytes. The pre-BCR comprising the Ig heavy chain and surrogate light chains, and protein tyrosine kinases such as Syk, Lyn, Blk and Bruton's tyrosine kinase (Btk) (6) , and can lead to a multitude of cellular the BCR that is composed of the surface Ig, are complexed to the signal transducing subunits Igα and Igβ (1) . Studies responses, such as proliferation, activation, differentiation or cell death. The current challenge in the field of B cell signaling with the µMT mouse that has a targeted deletion of the transmembrane exon of the Ig heavy chain (2) or the λ5T is to identify specific signaling pathways that associate with a particular cellular response. Recently, it has been demonmouse that lacks surrogate light chain (3) indicated that the inability of these mutant mice to express a pre-BCR can lead strated that adaptor proteins play a major role in interfacing tyrosine kinase activation by lymphocyte antigen receptors to the arrest of B cell development at a very early stage. In addition, mice with a compromised BCR resulting from the with selective downstream signaling molecules. One such adaptor molecule termed BLNK (7), SLP-65 (8) or BASH (9) truncation of the cytoplasmic tail of Igα (4) do not accumulate mature B cells in the periphery. Finally, the induced ablation has been identified in B cells and is specifically involved in BCR signaling. BLNK can associate with Btk (10) and also of BCR on mature peripheral B cells leads to their rapid cell death (5) . Taken together, these studies implied that signals couple Syk activation to Grb2, phospholipase C (PLC)-γ, Vav and Nck (7) , and is intimately associated with intracellular from the pre-BCR and BCR are required for the progression of B lymphopoiesis and the maintenance of B cell survival.
Ca 2ϩ mobilization which is essential for cell activation (11) .
BLNK contains a C-terminus SH2 domain, several SH3 rubber-stopper from a 5 ml syringe. Peritoneal cavity and bone marrow cells were obtained by injecting staining medium domains and a series of YXXP motifs in the N-terminus (7) (8) (9) . It bears striking homology to another adaptor protein (PBS containing 3% FCS and 0.1% NaN 3 ) into the peritoneal cavity and femur and tibia respectively using a 10 and 1 ml that is expressed in T cells (12) and intimately involved in TCR signaling. In general, the order of the signaling events syringe with a 26-gauge needle. All cells were treated with red blood cell lysing solution (0.15 M NH 4 Cl, 1 mM KHCO 3 from the TCR and BCR is quite similar, with the engagement of the antigen receptors triggering the activation of similar and 0.1 mM Na 2 EDTA) to eliminate erythrocytes. For FACS analyses, cells were stained with optimal amounts of FITC-, classes of intracellular cytoplasmic kinases. In analogy to BLNK in B cells, SLP-76-coupled TCR induced ZAP-70 (the phycoerythrin (PE)-and biotin-conjugated mAb for 10 min on ice, and washed 3 times with staining medium. Biotinequivalent of Syk) activation to Ca 2ϩ mobilization in T cells (13) . In addition, SLP-76 is essential for T cell development conjugated mAb were revealed with streptavidin-CyChrome. Flow cytometry analyses were performed on a FACScan as its inactivation in the mouse germline leads to a profound block in thymocyte maturation at a very early stage (14, 15) .
(Becton Dickinson, Mountain View, CA). Thus, given the central role of BLNK in BCR signaling and its
In vitro stimulation and proliferation assays similarity to SLP-76 in T cells, we have inactivated BLNK in the mouse to study its physiological role in B cell development Splenic B cells were obtained from wild-type and mutant mice and activation.
by negative selection using MACS (Miltenyi Biotech) with anti-CD43 mAb-coupled magnetic beads that bind T cells and macrophages. The purity of B cells obtained was Ͼ90% as Methods assessed by anti-B220 and anti-IgM mAb staining in FACS analysis. For the in vitro stimulation assay, 10 6 purified B cells
Generation of BLNK/SLP-65-deficient mice
were seeded into 48-well tissue culture plate and incubated The cDNA for BLNK/SLP-65 was obtained by RT-PCR of RNA with 10 µg/ml goat anti-mouse IgM F(ab)Ј 2 fragment overnight isolated from mouse spleens using primers 5Ј-AGTGin RPMI medium supplemented with 10% FCS. Cells were GCTTGAGTTCTTGAGGC-3Ј and 5Ј-AGAAAAGCTCGTGTGharvested and stained for the expression of activation markers. AACGCC-3Ј, and used to screen a mouse 129 genomic DNA A colorimetric MTT assay (Roche, Singapore) was used library. Restriction enzyme digestion, Southern blotting and according to the manufacturer's instructions to measure cell DNA sequencing were used to map a phage clone containing proliferation in vitro. Briefly, 5ϫ10 5 purified B cells were some 5Ј exons of BLNK. Subsequently, a targeting vector stimulated with varying concentrations of goat anti-mouse was constructed to replace the exon containing the starting IgM F(ab)Ј 2 fragment in a 96-well tissue culture plate. After ATG and a further 4.5 kb of DNA upstream with a neo r gene.
48 h, the cells were incubated with the MTT labeling reagent A 5 kb BamHI-ClaI fragment 5Ј and a 2 kb NheI-BamHI for a further 4 h followed by the addition of solubilization fragment 3Ј of the deleted exon were used as the long arm solution overnight. Cell proliferation was quantified using an and short arm of homology respectively. To inactivate BLNK ELISA reader at 570 nm wavelength. in the germline, 10 7 E14.1 embryonic stem (ES) cells were electroporated with 10 µg of NotI-linearized targeting vector
Immunizations of BLNK/SLP-65-deficient mice and selected with 300 µg/ml G418 (Gibco, Hong Kong, ROC)
The ability of BLNK -/-mice to mount a humoral immune and 2 µM gancyclovir. Double-drug-resistant ES cell clones response was assessed by immunizing the animals with the were screened by Southern blotting for homologous recombinhapten 4-hydroxy-3-nitrophenyl acetyl (NP). Wild-type and ants using probe A as shown in Fig. 1 . The frequency of mutant mice were immunized i.p. with 10 µg NP 25 -Ficoll in PBS targeting was 1:100. Two ES cell clones with the correct to examine their immune responses to a T cell-independent configuration of the targeted locus were injected into C57BL/ antigen. For the immune response to a T cell-dependent 6 blastocysts to generate chimeric mice for germline transmisantigen, mice were immunized i.p. with 100 µg alum-precipitsion of the mutant allele.
ated NP 17 -chicken globulin (CG). Sera were obtained from mice at day 0 and 8 of immunizations to detect the presence Antibodies of NP-specific antibodies in an ELISA. To detect NP-specific The following mAb used in the flow cytometry analyses were antibodies, the ELISA plates were coated with 50 µl of 5 µg/ purchased from PharMingen (San Diego, CA): anti-B220 ml NP-BSA and blocked with 3% BSA. Pre-immune and (RA3-6B2); anti-IgM (331.12), anti-IgD (1.3-5), anti-CD43 (S7), immune sera were added at various dilutions to the wells of anti-CD5 (53-7), anti-CD11b (M1/70), anti-CD23, anti-CD69, the ELISA plates. Specific antibodies of class IgM and IgG3 anti-CD86 (B7-2), anti-µ a (DS-1) and anti-µ b (AF6-78.25). The were quantified for the T-independent, and IgM and IgG1 for goat anti-mouse IgM F(ab)Ј 2 fragment used in the in vitro the T-dependent immune responses respectively. stimulation assays was obtained from Chemicon (Temecula, CA).
Results

FACS analyses
Generation of BLNK/SLP-65-deficient mice Tissues and cell preparations for flow cytometric analyses were prepared as previously described (16) . In brief, single-BLNK/SLP-65-deficient mice were generated by deleting the exon containing the starting codon ATG and a further 4.5 kb cell suspensions were obtained from spleen and lymph nodes by dissociation of these tissues with a plastic mesh and a of DNA upstream in mouse ES cells (Fig. 1 ). The deletion of the exon containing the ATG was verified by Southern blotting be found in 8-week-old mutant mice although they were reduced considerably by~3-fold compared to wild-type ( Fig. 1 ) and by DNA sequencing (data not shown). Two targeted ES cells were injected into mouse blastocysts to control. In addition, the population of re-circulating B220 high IgM low cells was also largely diminished by 2-to 4-generate chimera that were subsequently bred to produce mice carrying a germline mutation of BLNK/SLP-65. Homozyfold. To gain better insight into the specific B cell stage in which the BLNK/SLP-65 mutation manifests its effect, gous mutant mice obtained were designated BLNK -/-. The gene targeting strategy and the derivation of homozygous B220 ϩ IgM -cells in the bone marrow were further stained with anti-CD43 mAb to resolve pro-B and pre-B cells (17) . As mice are depicted in Fig. 1 (A and B respectively).
To ensure the inactivation of BLNK, RT-PCR was performed can be seen in Fig. 2 (lower panel), BLNK/SLP-65-deficient mice lack a population of B220 ϩ CD43 -pre-B cells that was on bone marrow and spleen samples with primers that correspond to the 5Ј and 3Ј portions of the BLNK cDNA. As reduced by 5-fold compared to wild-type animals. In addition, there was a 2-fold accumulation of B220 ϩ CD43 ϩ pro-B cells shown in Fig. 1(C) , no BLNK message was detected in the samples obtained from mutant mice compared to those from in the bone marrow of these mutant mice. The increase in the proportion of pro-B cells in BLNK -/-mice reflects an increase wild-type control. Thus, the BLNK loci have been disrupted.
Initial flow cytometric analyses using cell surface markers in the number of these cells as compared to wild-type mice (Table 1) . Thus, the inactivation of BLNK/SLP-65 results in a suggest that there were no detectable defects in the development of macrophages, T, NK or dendritic cells (data not severe inhibition of pro-B to pre-B cell transition. However, the block in B cell development is incomplete as a small pool shown), consistent with the fact that BLNK is not shown to be expressed in these cell types (7) (8) (9) Cells were obtained from one femur and tibia of mice that were 6-8 weeks old.
The number of B cells at each developmental stage was estimated on the basis of total cell count and flow cytometric analyses as shown in Fig. 2. cells in the peripheral lymphoid tissue (5). It is postulated that the BCR provides a low-level survival signal to the peripheral B lymphocytes that is distinct from the signal that is required age, BLNK mutant mice have only 7-and 2-fold fewer B cells than wild-type animals of comparable age respectively. This 
Absence of CD5 ϩ B cells in the peritoneal cavity of BLNK/ suggests that the number of peripheral B cells in BLNK mutant
SLP-65-deficient mice mice can accumulate with age. Thus BLNK is apparently not required for the maintenance of B cells in the periphery. The
Other than the conventional or B-2 cells found in the spleen and lymph nodes, another major subset of B cells, designated accumulation of B cells in BLNK -/-mice with age contrasted sharply with the situation in mb-1∆c/∆c mice (4) that have a B-1 cells, exists, and these cells are found mainly in the pleural and peritoneal cavities. These cells can be distinguished from truncation of the cytoplasmic tail of Igα leading to the expression of a compromised BCR. In mb-1∆c/∆c mice the peripheral conventional B cells by their cell surface phenotype. In contrast to B-2 cells that express high levels of B220 and B cell pool remains diminished regardless of the age of the animals.
IgD, and moderate levels of IgM, B-1 cells express low levels of B220 and IgD, and high levels of surface IgM. In addition, they express CD5, a marker found on T cells, and do not express CD23 (21). (Fig. 5 ). This suggests that BLNK is required for the generation of B-1 cells. Interestingly, as seen in Fig. 4 Cross-linking of BCR activates B lymphocytes, resulting in their up-regulation of co-stimulatory and activation molecules. I. This block in peripheral B cell maturation is even more evident in the lymph nodes of BLNK -/-mice compared to
Severe reduction of IgM low IgD high (Fraction I) B cells in the
To determine whether BLNK -/-B cells are functional and responsive to external stimuli, we treated purified splenic B control animals (Fig. 4) where in the latter all cells are found in Fraction I. Thus, although BLNK -/-B cells can seed the cells from wild-type and BLNK -/-mice with anti-IgM mAb in vitro. As shown in Fig. 6(A) , anti-IgM activated wild-type B peripheral lymphoid tissues and accumulate in numbers, the majority of them do not differentiate to the IgM low IgD high cells up-regulate their expression of CD69, an early activation marker, as well as the co-stimulatory molecule, CD86 (B7-2). mature B cell stage.
In contrast, BLNK -/-B cells did not up-regulate either the mice with NP conjugated to CG (NP-CG). As shown in Fig.  7 (B) and in contrast to the situation for the T cell-independent antigen, BLNK -/-mice can mount an effective immune response to NP-CG that is comparable to wild-type animals, both in terms of IgM and IgG1 secretion. Thus taken together, the data indicate that BLNK -/-mice have an impaired immune response to T-independent but not T-dependent antigens.
Discussion
Mice deficient for the adaptor protein BLNK/SLP-65 exhibit a severe block in early B cell development at the pro-B to pre-B cell transition stage where the pre-BCR is expressed. This is consistent with the notion that a signal from the pre-BCR is required for the progression of early B lymphopoiesis (1) and presumably BLNK is needed for the transduction of such a developmental signal. However, this early developmental block is incomplete as sIgM ϩ B cells do develop that could eventually seed the peripheral lymphoid tissues. It is not known currently why and how these sIgM ϩ B cells could bypass the developmental block at the pro-B to pre-B cell transition stage. It is intriguing to speculate that perhaps these sIgM ϩ B cells encode for polyreactive antibodies that recognize certain environmental or self ligands with higher affinities and this heightened interaction provides the signal that could compensate for BLNK deficiency during the devel- independent antigens while maintaining a normal T celldependent immune response. While the current work is in progress, two other groups have also generated mice deficient in BLNK or SLP-65 (22, 23) . The phenotypes of the three independently generated BLNK mutant mice (22,23 and expression of CD69 or CD86, indicating that they are nonresponsive to activation via BCR cross-linking. current study) are comparable and together confirmed the physiological role of BLNK in B cell development. However, Activated wild-type B cells also undergo cell proliferation upon BCR cross-linking in a manner proportional to the we differ with respect to the inability of our BLNK -/-B cells to up-regulate the expression of the activation markers CD69 concentration of stimulating anti-IgM mAb present (Fig. 6B) . However, BLNK -/-B cells do not proliferate even in the and CD86 upon anti-IgM stimulation in vitro. This difference could be due to the use of an enriched population of B cell presence of increasing amount of stimulant given. Thus, these data indicate that BLNK -/-B cells are non-responsive to BCR in our assay as compared to the use of total splenocytes by the other groups (22, 23) . It is conceivable that in the latter, cross-linking in vitro.
other factors such as the availability of T cell help in the form Impaired T cell-independent but not T cell-dependent immune of secreted cytokines might overcome the inability of BLNK -/-responses in BLNK -/-mice B cells to respond to anti-IgM stimulation in vitro. Another possible explanation for the difference in our data could be Antigens that elicit an antibody response from B cells can be classified either as T independent or T dependent according the difference in the timing of assessment of the activation of BLNK -/-B cells. In our study, we examine the up-regulation to their dependency on CD4 ϩ T cell help. To examine whether BLNK -/-mice can mount an efficient immune response to of the activation markers after an overnight stimulation of Ͻ18 h. Since BLNK is an adaptor molecule that facilitates the exogenous antigens, we first immunized mice with NP coupled to Ficoll (NP-Ficoll), a T cell-independent antigen. The primary interaction of other proteins, the absence of BLNK may simply lead to a slower kinetic of activation of mutant B lymphocytes antibody response to NP-Ficoll is mainly of the IgM and IgG3 class. As can be seen in Fig. 7(A) , BLNK -/-mice showed compared to wild-type cells. Indeed, further experiments will have to be conducted to determine the kinetics (if any) and undetectable IgM or IgG3 antibody response to NP-Ficoll 8 days after immunization compared to the wild-type control.
parameters of activation of BLNK -/-B cells in vitro. Finally, our data indicating the inability of BLNK -/-B cells to proliferate For the T-cell-dependent immune response, we immunized Fig. 7 . BLNK -/-mice have impaired immune response to T cell-independent but not T cell-dependent antigens. Groups of three wild-type (j) and BLNK -/-mice (d) were immunized i.p. with (A) 10 µg NP-Ficoll, a T cell-independent antigen, and (B) 100 µg alum-precipitated NP-CG, a T cell-dependent antigen. Sera were collected 8 days after immunization and quantified for the presence of NP-specific antibodies of various Ig classes in an ELISA using NP-BSA as the coating antigen. The immune sera were diluted several fold and the absorbance values for the indicated dilution (e.g. 1:100 for IgG3 in the T cell-independent immune response) were plotted. Pre-immune sera were negative for the presence of NP-specific antibodies and are not shown.
and be activated by anti-IgM stimulation in vitro would correlmajor substrate phosphorylated by Syk that leads to calcium mobilization by PLC-γ2 (11) . Recently, it has been shown that ate much better with the inability of these mutant B cells to mount a T cell-independent immune response in vivo.
BLNK can also bind to the SH2 domain of Btk (10) . Perhaps, it is this disruption in Btk-BLNK interaction that is responsible It has been shown that BCR expression is required for the maintenance of peripheral B cells (5) . Our additional data on for the lack of B-1 cells in BLNK -/-mice. It remains to be established whether B-1 cells failed to be generated or, if the accumulation of peripheral B cells in BLNK -/-mice with age suggest that signals transduced by BLNK are not involved generated, fail to be maintained in BLNK -/-mice. Btk mutation is responsible for X-linked agammaglobulinein the persistence or maintenance of lymphocytes. This is in contrast to the situation in mb-1∆c/∆c mice that have a mia (XLA), a human immunodeficiency syndrome (34). A recent report indicates that mutation in BLNK can also cause compromised BCR and in which the peripheral B cell pool does not expand with increasing age of the animals (4).
human immunodeficiency (35). Since BLNK -/-mice resemble xid mice, it is now of great interest to establish whether These data together would imply that the cell survival signal mediated by Igα in the BCR complex is not propagated by mutation in BLNK may be responsible for a large proportions of the human immunodeficiency that is not associated with a BLNK. Although BLNK -/-B cells can accumulate in the periphery, the majority of these cells failed to mature to a mutation in Btk. This is of particular significance as BLNK is expressed only in B cells and, unlike Syk (27,28) or PI-3K IgM low IgD high stage, suggesting that BLNK-transduced signal is needed for the final maturation of B lymphocytes in the (29, 30) , its deficiency does not result in embryonic lethality. Finally, disruption of SLP-76 in T cells leads to a complete secondary lymphoid tissues.
The developmental and functional defects in BLNK -/-mice block in T cell development (14, 15) , whereas IgM ϩ B cells can develop in the absence of BLNK/SLP-65 (22,23 and bear striking resemblance to xid mice that lack Btk (24-26). Both mutant mice have a block in primary B lymphopoeisis, current study). This would suggest that although the ordered pathways for the development of T and B are quite similar, lack B-1 and mature B cells but accumulate immature IgM high IgD low and IgM high IgD high cells in the periphery; and their mechanisms for the control and regulation of maturation might be quite different in some aspect (36) . The availability are unable to mount immune responses to T-independent antigens. To a lesser extent, the B cell developmental defect of BLNK -/-mice will no doubt aid in the further study of the B cell differentiation process. in BLNK -/-mice is also similar to that of mutant mice lacking the tyrosine kinase Syk (27,28) and to mice with disruption of Acknowledgements the p85α subunit of phosphoinostitide 3-kinase (PI-3K) (29, 30) . All these mutant mice had a block in the pro-B to
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